For good it seems that we are now entering into planning for what we will do with the third tranche, as a working group starts today, Friday, on data analysis for Cyprus as well. The Deputy Director of Pharmaceutical Services, Elena Panayotopoulou, speaking to “P” said that in a teleconference with Coreper, they will be presented with studies on the data of Israel, which is the first country in the world to launch a third aid dose for citizens over 60 At the same time, he clarified that the administration of the third dose concerns only the mRNA vaccines, ie Pfizer / BioNTech and Moderna, and pointed out that the third dose does not concern the general population, but specific categories, such as the immunocompromised and those belonging to the vulnerable groups. He reminded that the American Drug Administration (FDA) has already approved the administration of a third dose.
Prioritization of citizens
Therefore, the data collected so far by the European Medicines Agency (EMA) in relation to the forthcoming decisions and instructions for the administration of a third dose of the Covid-19 vaccine are under evaluation. As everything shows, it is not ruled out that by the end of August, the organization will issue instructions to the states regarding the prioritization and the groups of citizens that will receive the third, supportive installment.
More about the issue in the printed version of “P” and for the subscribers of POLITIS PREMIUM the digital version of the newspaper in PDF at the same time with its printed circulation daily from 05.00 in the morning.
